XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash Flows from Operating Activities:    
Net income (loss) $ 14,061,076 $ (2,520,994)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Change in fair value of warrant liabilities (16,965,231) 1,400,000
Interest earned on marketable securities held in Trust Account (257,489) (9,642)
Transaction costs incurred in connection with IPO 520,319
Changes in operating assets and liabilities:    
Prepaid expenses 64,369 (340,510)
Accrued expenses 2,855,084 331,346
Net cash used in operating activities (242,191) (619,481)
Cash Flows from Investing Activities:    
Investment of cash in Trust Account (230,000,000)
Net cash used in investing activities (230,000,000)
Cash Flows from Financing Activities:    
Proceeds from sale of Units, net of underwriting discounts paid 226,000,000
Proceeds from sale of Private Placement Warrants 6,000,000
Proceeds from promissory note – related party 149,980 60,910
Advances from related parties 2,500  
Over payment of promissory note 25,000
Refund of over payment of promissory note (155,410)
Payment of offering costs (374,749)
Net cash provided by financing activities 152,480 231,555,751
Net Change in Cash and cash equivalents (89,711) 936,270
Cash and cash equivalents – Beginning 91,407
Cash and cash equivalents – Ending 1,696 936,270
Non-cash investing and financing activities:    
Remeasurement of Class A ordinary shares subject to redemption amount 257,489 21,573,572
Deferred underwriting fee payable 8,650,000
Initial classification of Class A ordinary shares subject to possible redemption $ 230,000,000